Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Purchase of Shares by Employee Benefit Trust

26th Mar 2007 07:00

23 March 2007

Shire plc ("Shire")

Purchase of Shares by Employee Benefit Trust

Shire has been notified that on 23 March 2007, the Shire plc Employee Benefit Trust (the "Trust") purchased 49,877 Ordinary Shares of Shire plc ("Shares") at an average price of 1082.80 pence per Share and 40,000 American Depositary Shares of Shire plc at an average price of USD 63.9517 per Share. This purchase was made pursuant to the Trustee's irrevocable, non-discretionary programme to purchase Ordinary Shares of Shire plc ("Shares") and American Depositary Receipts of Shire plc ("ADR's") for the benefit of the Trust during the period commencing on 01 March 2007 and ending on 30 June 2007.

All of the employees of Shire plc and its subsidiaries, including the Executive Directors and persons exercising managerial responsibility, are potential beneficiaries of the Trust. The Executive Directors and persons exercising managerial responsibility over Shire are therefore deemed to have an interest in the Shares held by the Trust.

For further information please contact:

Investor Relations Clĩa Rosenfeld (Rest of the World) +44 1256 894 160 Eric Rojas (North America) +1 484 595 8252 Notes to editorsSHIRE PLC

Shire's strategic goal is to become the leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire's focused strategy is to develop and market products for specialty physicians. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company's website: www.shire.com.

2Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Press Release

Registered in England 5492592 Registered Office as above

SHIRE PLC

Related Shares:

Shire
FTSE 100 Latest
Value8,774.65
Change-17.15